Shanghai Medicilon Inc. (688202.SS) — Stock Score Summary

Shanghai Medicilon Inc. (688202.SS) has a MoatMap StockRank of 40/100 based on Quality (43/100), Value (37/100), and Momentum (47/100) factor scores. The current signal is HOLD. Shanghai Medicilon is a China-based CRO/CDMO. While it operates in our target sector, it faces severe geopolitical headwinds from Western legislative efforts (such as the US Biosecure Act) aimed at decoupling biotech supply chains from China, destroying its international growth runway.

Shanghai Medicilon Inc. provides comprehensive pre-clinical contract research organization (CRO) services, covering drug discovery, pharmaceutical analysis, and IND filing. The company's competitive moat lies in its ability to offer fully integrated pre-clinical services that meet both Chinese and international GLP standards. It is a leading mid-sized pre-clinical CRO in China, serving a diverse global and domestic biopharmaceutical client base.

Key Financial Metrics

Price$7.61
Market Cap$1.2B
P/E (Forward)24.68
Price/Book3.62
Return on Equity-6.7%
Return on Invested Capital-8.6%
Debt/Equity13.94
Gross Margin18.1%
Operating Margin4.6%
Revenue Growth36.5%
Free Cash Flow$18K

Shanghai Medicilon Inc. operates in the Biotechnology industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Shanghai Medicilon Inc.’s (688202.SS) StockRank?
MoatMap’s StockRank for Shanghai Medicilon Inc. (688202.SS) is 40/100, with a Hold signal. It is a composite of Quality (43), Value (37), and Momentum (47) factor ranks across MoatMap’s 19,000+ stock universe.
Does Shanghai Medicilon Inc. have an economic moat?
Shanghai Medicilon Inc. (688202.SS) has a Quality factor score of 43/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Shanghai Medicilon Inc. a buy, hold, or sell?
MoatMap’s current signal for Shanghai Medicilon Inc. (688202.SS) is Hold, based on a StockRank of 40/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Shanghai Medicilon Inc. in?
Shanghai Medicilon Inc. (688202.SS) operates in the Healthcare sector, specifically the Biotechnology industry (China).
Browse all ranked stocks688202.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock